Susquehanna International Group
GLSI icon

Susquehanna International Group’s Greenwich LifeSciences GLSI Stock Holding History

Susquehanna International Group’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,870
Closed -$715K – 12464
2024
Q1 		$715K Buy
+35,870
New +$442K ﹤0.01% 7657
2023
Q2 		– Sell
-37,100
Closed -$512K – 12457
2023
Q1 		$512K Buy
+37,100
New +$589K ﹤0.01% 8509

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group's GLSI Position: Q2 2024 in Review

Susquehanna International Group sold out of Greenwich LifeSciences (GLSI) in Q2 2024, closing a stake of 35,870 shares — an estimated $715K sold.

Susquehanna International Group first reported a position in GLSI in Q1 2023 and held it in 2 quarters. The position peaked at $715K in Q1 2024. 34 funds tracked by Wall St. Rank hold GLSI as of Q2 2024.

  • Susquehanna International Group reported no remaining Greenwich LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 35,870 Greenwich LifeSciences shares in Q2 2024, an estimated $715K.
  • Susquehanna International Group first reported a position in Greenwich LifeSciences in Q1 2023 and held it in 2 quarters.
  • Susquehanna International Group's Greenwich LifeSciences position peaked at $715K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.